GRI Bio Statistics
NASDAQ: GRIHealthcareBiotechnologyUSD
1.68-0.17 (-9.19%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
GRI Bio by the numbers
GRI Bio has a market capitalization of $3.7 million based on 2.19M shares outstanding. With trailing EPS of $-14.71, GRI Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.8% below its 50-day average and 39.5% below its 200-day average.
Average daily trading volume is 328.06K shares, or about $551,136 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GRI valuation vs. peer median
| Metric | GRI | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.67M | $3.54M | +4% |
| Avg. volume | 328.06K | 316.45K | +4% |
Peer median across 8 companies: JUNS, PCSA, CLDI, EOCN, ONCO, HCWB, SXTP, SLXN.
Valuation
- Market cap
- $3.67M
- EPS (TTM)
- $-14.71
- Shares outstanding
- 2.19M
Price and trading
- Previous close
- 1.85
- Open
- 1.85
- Day range
- 1.68 – 1.88
- 52-week range
- 1.36 – 64.12
- Beta
- —
- Volume
- 52.51K
- Average volume
- 328.06K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2025
Additional statistics
- Market Cap
- 3.67M
- Forward Pe
- -0.84
- Eps
- -14.71
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 64.12
- Week52 Low
- 1.36
- Avg Volume
- 328.06K
- Shares Outstanding
- 2.19M
- Ma50
- 1.86
- Ma200
- 2.78
- Earnings Date
- Aug 12, 2025
- Pct From52w High
- -97.38%
- Pct From52w Low
- 23.53%